Positions

Overview

  • Dr. Carlo M. Contreras completed his surgical oncology training at the M.D. Anderson Cancer Center in Houston, TX. There, his focus was on the most effective surgical approaches to hepatobiliary and pancreatic malignancies. As a member of the UAB Surgical Oncology faculty he cares for patients with a wide variety of malignancies including skin, soft tissue, and gastrointestinal. He promotes a patient-centered approach, and feels that effective communication is paramount in the multidisciplinary care of his patients. Dr. Contreras is pleased to offer a broad range of oncologic therapies, including minimally invasive and robotic approaches. He is the Director of the UAB Surgical Oncology Tissue Bank, and participates in clinical trials.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Cutaneous melanoma, version 2.2019Journal of the National Comprehensive Cancer Network.  17:367-402. 2019
    2019 Gallbladder Cancer: Diagnosis, Surgical Management, and Adjuvant TherapiesSurgical Clinics of North America.  99:337-355. 2019
    2019 Healthcare disparities in outcomes of patients with resectable pancreatic cancerAmerican Journal of Surgery.  217:725-731. 2019
    2018 Timed Stair-Climbing as a Surrogate Marker for Sarcopenia Measurements in Predicting Surgical Outcomes.Journal of Gastrointestinal Surgery2018
    2018 Merkel Cell Carcinoma, Version 1.2018Journal of the National Comprehensive Cancer Network.  16:742-774. 2018
    2018 PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoidsProceedings of the National Academy of Sciences.  115:E5066-E5075. 2018
    2018 Chronic granulomatous dermatitis induced by talimogene laherparepvec therapy of melanoma metastasesJournal of Cutaneous Pathology.  45:48-53. 2018
    2018 Pathological complete response after neoadjuvant pembrolizumab and radiationClinical and Experimental Dermatology2018
    2017 Increased pancreatic cancer survival with greater lymph node retrieval in the National Cancer Data BaseAmerican Journal of Surgery.  214:442-449. 2017
    2017 Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer PathogenicityACS Chemical Biology.  12:905-911. 2017
    2017 Chemoproteomic Screening of Covalent Ligands Reveals UBA5 As a Novel Pancreatic Cancer TargetACS Chemical Biology.  12:899-904. 2017
    2017 Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicityChemical Communications.  53:7234-7237. 2017
    2016 Pancreatic cancer survivors’ preferences, barriers, and facilitators related to physical activity and diet interventionsJournal of Cancer Survivorship.  10:981-989. 2016
    2016 Comparative Proteomic Analysis of Whole-Gut Lavage Fluid and Pancreatic Juice Reveals a Less Invasive Method of Sampling Pancreatic Secretions.Clinical and Translational Gastroenterology.  7:e174. 2016
    2016 Timed Stair Climbing is the Single Strongest Predictor of Perioperative Complications in Patients Undergoing Abdominal SurgeryJournal of The American College of Surgeons.  222:559-566. 2016
    2011 Radiographic and clinical factors associated with improved outcomes in advanced cancer patients with bowel obstructionJournal of Palliative Medicine.  14:990-996. 2011
    2011 Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: A study of 112 patients with limited lung metastatic diseaseJournal of The American College of Surgeons.  213:62-69. 2011
    2011 Adjuvant trials for pancreatic cancer: where are we going and what is needed?Clinical Investigation.  1:651-667. 2011
    2010 Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastasesAnnals of Surgical Oncology.  17:2870-2876. 2010
    2010 Staging systems: Is there a surgical staging and a medical one? A surgeon's perspectiveJournal of Hepato-Biliary-Pancreatic Sciences.  17:438-439. 2010
    2010 Metastasectomy of combined liver and lung colorectal cancer metastasesCurrent Colorectal Cancer Reports.  6:83-88. 2010
    2009 Staging laparoscopy enhances the detection of occult metastases in patients with pancreatic adenocarcinomaJournal of Surgical Oncology.  100:663-669. 2009
    2007 1-41 Sentinel Node Biopsy Before Neoadjuvant Chemotherapy for Determining Axillary Status and Treatment Prognosis in Locally Advanced Breast CancerBreast Diseases.  18:74-75. 2007
    1999 In vitro recoating of reovirus cores with baculovirus-expressed outer- capsid proteins μ1 and σ3Journal of Virology.  73:3941-3950. 1999
    1998 Binding site for S-adenosyl-L-methionine in a central region of mammalian reovirus λ2 protein. Evidence for activities in mRNA cap methylationJournal of Biological Chemistry.  273:23773-23780. 1998

    Chapter

    Year Title Altmetric
    2012 Hepatic steatosis, steatohepatitis, and chemotherapy-related liver injury.  999-1005. 2012
    2011 Multidisciplinary care of the hepatocellular carcinoma patient.  81-88. 2011
    2011 Neuroendocrine cancers.  301-324. 2011

    Education And Training

  • Doctor of Medicine, Northwestern University 2003
  • University of Wisconsin Hospital & Clinics, Residency 2008
  • MD Anderson Cancer Center, Postdoctoral Fellowship 2010
  • Full Name

  • Carlo Contreras